BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 17217977)

  • 1. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.
    Nelson CD; Palermo LM; Hafenstein SL; Parrish CR
    Virology; 2007 May; 361(2):283-93. PubMed ID: 17217977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex and Dynamic Interactions between Parvovirus Capsids, Transferrin Receptors, and Antibodies Control Cell Infection and Host Range.
    Callaway HM; Welsch K; Weichert W; Allison AB; Hafenstein SL; Huang K; Iketani S; Parrish CR
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29695427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.
    Schofield DJ; Stephenson JR; Dimmock NJ
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2431-9. PubMed ID: 9349461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Near-Atomic Resolution Structure of a Highly Neutralizing Fab Bound to Canine Parvovirus.
    Organtini LJ; Lee H; Iketani S; Huang K; Ashley RE; Makhov AM; Conway JF; Parrish CR; Hafenstein S
    J Virol; 2016 Nov; 90(21):9733-9742. PubMed ID: 27535057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is bivalent binding of monoclonal antibodies to different antigenic areas on the hemagglutinin of influenza virus required for neutralization of viral infectivity?
    Yoden S; Kida H; Yanagawa R
    Arch Virol; 1985; 85(3-4):209-16. PubMed ID: 2411245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of chimpanzee Fab fragments by repertoire cloning and production of a full-length humanized immunoglobulin G1 antibody that is highly efficient for neutralization of dengue type 4 virus.
    Men R; Yamashiro T; Goncalvez AP; Wernly C; Schofield DJ; Emerson SU; Purcell RH; Lai CJ
    J Virol; 2004 May; 78(9):4665-74. PubMed ID: 15078949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purified feline and canine transferrin receptors reveal complex interactions with the capsids of canine and feline parvoviruses that correspond to their host ranges.
    Palermo LM; Hafenstein SL; Parrish CR
    J Virol; 2006 Sep; 80(17):8482-92. PubMed ID: 16912298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two single-chain antibodies that neutralize canine parvovirus: analysis of an antibody-combining site and mechanisms of neutralization.
    Yuan W; Parrish CR
    Virology; 2000 Apr; 269(2):471-80. PubMed ID: 10753725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
    Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
    Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
    J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid.
    Strassheim ML; Gruenberg A; Veijalainen P; Sgro JY; Parrish CR
    Virology; 1994 Jan; 198(1):175-84. PubMed ID: 8259653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A monoclonal antibody specific for reovirus outer-capsid protein sigma3 inhibits sigma1-mediated hemagglutination by steric hindrance.
    Nason EL; Wetzel JD; Mukherjee SK; Barton ES; Prasad BV; Dermody TS
    J Virol; 2001 Jul; 75(14):6625-34. PubMed ID: 11413330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
    Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
    Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemagglutinin 1-specific immunoglobulin G and Fab molecules mediate postattachment neutralization of influenza A virus by inhibition of an early fusion event.
    Edwards MJ; Dimmock NJ
    J Virol; 2001 Nov; 75(21):10208-18. PubMed ID: 11581389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two influenza A virus-specific Fabs neutralize by inhibiting virus attachment to target cells, while neutralization by their IgGs is complex and occurs simultaneously through fusion inhibition and attachment inhibition.
    Edwards MJ; Dimmock NJ
    Virology; 2000 Dec; 278(2):423-35. PubMed ID: 11118365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral Capsid, Antibody, and Receptor Interactions: Experimental Analysis of the Antibody Escape Evolution of Canine Parvovirus.
    López-Astacio RA; Adu OF; Goetschius DJ; Lee H; Weichert WS; Wasik BR; Frueh SP; Alford BK; Voorhees IEH; Flint JF; Saddoris S; Goodman LB; Holmes EC; Hafenstein SL; Parrish CR
    J Virol; 2023 Jun; 97(6):e0009023. PubMed ID: 37199627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties and characterization of monoclonal antibodies to Tacaribe virus.
    Howard CR; Lewicki H; Allison L; Salter M; Buchmeier MJ
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1383-95. PubMed ID: 2410550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A haemagglutinin (HA1)-specific FAb neutralizes influenza A virus by inhibiting fusion activity.
    Edwards MJ; Dimmock NJ
    J Gen Virol; 2001 Jun; 82(Pt 6):1387-1395. PubMed ID: 11369883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding site on the transferrin receptor for the parvovirus capsid and effects of altered affinity on cell uptake and infection.
    Goodman LB; Lyi SM; Johnson NC; Cifuente JO; Hafenstein SL; Parrish CR
    J Virol; 2010 May; 84(10):4969-78. PubMed ID: 20200243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies.
    McCullough KC; Crowther JR; Butcher RN; Carpenter WC; Brocchi E; Capucci L; De Simone F
    Immunology; 1986 Jul; 58(3):421-8. PubMed ID: 3015780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.